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-. (r+ = 0.974, n = 103). Using sera from patients with liver diseases and sera from patients with secondary hyperparathyroidism yielded a cross-reactivity of 20% for circulating liver ALP (and its membrane-bound isoform). In patients receiving renal transplants, Z-score analysis revealed that after transplantation the increase in bone ALP activity is more pronounced than total ALP activity. In tumor patients, receiver-operating characteristic analysis revealed that bone ALP activity shows the same diagnostic efficacy as total ALP activity in the detection of bone metastases (as assessed by bone scintigraphy).
Method for determination of bone alkaline
In multiple myeloma patients, suppressed osteoblast activity was well detectable by bone ALP activity determination. cells [1] entering the circulation as a dimeric protein by phosphatidylinositol glycanase activity [2] or by formation of membrane vesicles [3] .
Previous studies have shown that bone ALP can be considered a marker of bone formation in vitro [4] and in vivo [5] .
Specific determination
of bone ALP serum concentrations shows higher discriminating power than does total ALP activity in the detection of bone diseases [1] .
The ALPs of bone and liver are coded by a single gene but differ in their posttranslational modifications (e.g., glycosylation and sialylation; for review see 6). Methods for specific determination of bone ALP currently in use include electrophoretic separation [7] , precipitation of the analyte with wheat germ lectin [8] , a heat-inactivation method (based on the different susceptibility of skeletal and hepatic isoform activities after incubation at 56 #{176}C) [9] [10] [11] [12] , or an IRMA [1, 13] . Electrophoretic separation is technically cumbersome and often exhibits poor resolution in the differentiation between liver and bone ALP isoforms [7] ; the same applies to the heat-inactivation principle. mm at 45 #{176}C, rinsed with water, dried, and scanned with a densitometer at 600 nm. To improve the separation between bone and liver isoforms, we treated the sera with neuraminidase for 30 mm at 37 #{176}C. After removal of sialic acid, both isoforms migrate more cathodically, and the separation between them is increased.
An ALP isoform migrating more anodically than serum liver ALP was previously identified as a complex consisting of cell membranes and liver ALP (for review see 7) . No external calibrator was used to calibrate the electrophoretic procedure.
However, sera from patients with liver and bone diseases were regularly run to check whether the electrophoretic mobility of the ALP isoforms was reproducible.
All commercially available kits used here were performed according to the manufacturers' recommendations.
STATISTICAL ANALYSIS
The 
Results

IMPRECISION
Three different human serum pools obtained from patients with kidney disease and from apparently healthy persons were analyzed 20 times to assess within-run imprecision and 9 times in different series to determine between-run imprecision ( Table 1) . (Fig. 1 ).
There was a linear relation between the absorbance values obtained with the different calibrators and their assigned values (Fig. 2) (Fig. 3) .
The results of a crossover study involving the calibrators of both bone ALP assays are shown in Table 2 (Table 3) . These cross-reactivity data were further corroborated by examining another 20 samples from patients with severe secondary hyperparathyroidism of renal origin (the bone isoform constituting >90% of total activity) and another 20 samples from patients with different hepatobiliary diseases (the liver isoform(s) constituting >90% of total activity). The undiluted samples were assayed for total and bone ALP activity (by the alternative method for determination of total ALP activity; see Materials and Methods). The ratios between measured bone and total ALP activities were calculated: 0.951 ± 0.129 (mean ± SD) for bone disease patients and 0.220 ± 0.061 for liver disease patients. The ratio between these two mean values-23%-gives a direct estimate of the cross-reactivity with liver ALP.
REFERENCE INTERVAL
In apparently healthy adults, bone ALP activity concentrations were higher in men than in women (P <0.00 1). The reference intervals (2.5th-97.Sth percentile) in these adults were 7-35 U/L (median 16 U/L) (men) and 7-23 U/L (median 13 U/L) (women) (Fig. 4) .
CLINICAL USEFULNESS
In patients receiving renal transplants, bone ALP activity concentrations significantly increased 3 months after renal transplantation (mean ± SE 21.0 ± 2.7 U/L) as compared with the values before (10.9 ± 1.1 U/L) (P <0.001) (Fig. 5) . Z-score analysis reveals that bone ALP mass and activity concentrations showed a more pronounced increase than the total ALP activity concentrations (Table 4 ). In patients with bone metastases (according to scmntigraphic 
Patients
with multiple myeloma showed markedly decreased values of bone ALP activity concentrations (Z-score:
In tumor patients without bone metastases, Z-score values were lower for bone ALP mass and activity concentrations than for total ALP activity concentrations (P <0.05).
In tumor patients with bone metastases, no significant differences were observed between these three assays (P >0.05).
In multiple The shaded area denotes the reference range (mean ± 2 SD). (Fig. 7) .
Discussion
The assay examined for determination of bone ALP activity concentrations is characterized by a linear relation between the assigned activity concentrations of the calibrators and the mea- kit with circulating liver ALP was 20%. In contrast, Gomez et al. [20] reported that Alkphase-B shows a cross-reactivity with circulating liver ALP of only 5%. They used sera from patients with primary biliary cirrhosis after heat inactivation of bone ALP activity, assessing the ratio of measured bone ALP activity to the total ALP activity, but showed no data concerning the ratio of measured bone ALP activity to total ALP activity in sera from patients predominantly containing the bone isoform [20] . The method for determination of cross-reactivity used in this study corresponds to that used by Garnero and Delmas [1] , who found a cross-reactivity of 16% for the IRMA. Lawson et al. [21] prepared an antibody with a fivefold greater response with liver ALP than with bone ALP. However, the estimation of bone 60 100 -Specificity [%I ALP by using this antibody is indirect, being based on the difference between total and liver ALP activity.
The diagnostic validity of the assay examined in this study is strongly limited in patients with severe liver diseases; however, because of the preferential reactivity of the antibody used in the determination of bone ALP activity concentrations, the values should remain within the normal range if total ALP activity does not exceed two times the upper reference limit [14] .
The values found with Alkphase-B in apparently healthy persons were higher in men than in women. This may be due to the anti-resorptive effect of estrogens on bone metabolism [13] . The relation between bone ALP activity and mass concen- In patients receiving renal transplants, an increase in bone ALP can be observed, which is most probably due to an activating effect of cyclosporin A [15] . Both assays for determination of bone ALP show a more pronounced increase in the follow-up of patients after renal transplantation.
Equally, Garnero and Delmas [1] , studying patients with Paget disease receiving treatment with bisphosphonates, found that the percent decrease is more pronounced in bone ALP mass concentrations than in total ALP activity.
Our results show strongly increased values for both bone ALP assays in patients with bone metastases (as compared with those without bone metastases), which conflicts with the results of van Hoof et al. [22] as well as Stieber et al. [23] , who did not find such statistically significant differences, which may be explained by the different localizations of the primary tumors as well as by the different character of the bone lesions (osteoblastic, osteolytic, and mixed). Burlina et al. [24] reported that the determination of bone ALP by using wheat germ lectin precipitation is more specific for the identification of bone metastases than is total ALP activity.
Our results in multiple myeloma patients, in whom osteoblast activity is often suppressed [25] , show that all assays are capable of detecting decreased bone formation; however, slightly lower Z-score values of the IRMA are given here.
Our findings concerning the low discriminating power of the carboxyl-terminal propeptide of procollagen type I is in accordance with previous findings in patients with postmenopausal osteoporosis [26] .
In conclusion, we found that, in spite of a marked crossreactivity of the antibody used in the assay with circulating liver ALP, the assay provides useful information in the diagnosis of bone diseases, which may be considered comparable with those of other ALP assays.
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